T-cell-binding nanoparticles bypass the complexities of in vitro gene transfer to deliver genes to T cells within the host.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Maus, M. V. & June, C. H. Clin. Cancer Res. 8, 1875–1884 (2016).
Maude, S. L. et al. Blood 125, 4017–4023 (2015).
Smith, T. T. et al. Nat. Nanotech.http://dx.doi.org/10.1038/nnano.2017.57 (2017).
Smith, T. T. et al. J. Clin. Invest.http://dx.doi.org/10.1172/JCI87624 (2017).
Stephan, S. B. et al. Nat. Biotechnol. 33, 97–101 (2015).
Abramson, J. S. et al. 58th ASH Annu. Meet. Expos. Abstr. 4192 (2016); https://ash.confex.com/ash/2016/webprogram/Paper95897.html
Neelapau, S. S. et al. 58th ASH Annu. Meet. Expos. Abstr. LBA-6 (2016); https://ash.confex.com/ash/2016/webprogram/Paper98715.html
Mangraviti, A. et al. ACS Nano 9, 1236–1249 (2015).
Li, X. et al. Biomaterials 84, 157–166 (2016).
Kim, J. et al. Acta Biomater. 41, 293–301 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maus, M. Immunoengineering: Valet parking for CAR genes. Nat Biomed Eng 1, 0085 (2017). https://doi.org/10.1038/s41551-017-0085
Published:
DOI: https://doi.org/10.1038/s41551-017-0085